Philippe Laffont’s AbbVie ABBV Stock Holding History

Philippe Laffont’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-8,406	Closed	-$744K	–	154
2019 Q4	$744K	Buy	+8,406	New	+$698K	0.01%	156

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Philippe Laffont's ABBV Position: Q1 2020 in Review

Philippe Laffont sold out of AbbVie (ABBV) in Q1 2020, closing a stake of 8,406 shares — an estimated $744K sold.

Philippe Laffont first reported a position in ABBV in Q4 2019 and held it in 1 quarter. The position peaked at $744K in Q4 2019. 2,225 funds tracked by Wall St. Rank hold ABBV as of Q1 2020.

Philippe Laffont reported no remaining AbbVie position as of Q1 2020 after selling out during the quarter.
Philippe Laffont sold 8,406 AbbVie shares in Q1 2020, an estimated $744K.
Philippe Laffont first reported a position in AbbVie in Q4 2019 and held it in 1 quarter.
Philippe Laffont's AbbVie position peaked at $744K in Q4 2019.
2,225 funds tracked by Wall St. Rank held AbbVie as of Q1 2020.

Based on Coatue Management's 13F filing for Q1 2020, filed 15 May 2020.